FDA Okays DHE Nasal Spray for Acute Migraine

This post was originally published on Medscape

You will shortly be re-directed to the publisher's website

Atzumi combines a proprietary advanced powder and device technology to simplify nasal delivery of dihydroergotamine for acute treatment of migraine.
Medscape Medical News